IONQ Trading Decision - Executive Summary
December 6, 2025
THE BOTTOM LINE
VERDICT: SPECULATIVE BUY (Mad Money Only) - NOT AN INVESTMENT
Recommended Allocation: 1-3% of total portfolio (NOT 23.9%)
Price Target: $65 (23% upside)
Stop Loss: $47 (10% downside) - MANDATORY
Time Horizon: 2 weeks (exit by December 19)
WHAT YOU NEED TO KNOW
The Good
- Real Technology: 99.99% qubit fidelity world record (genuine breakthrough)
- Explosive Growth: +222% revenue growth YoY
- Government Catalyst: Trump admin reportedly considering equity stakes in quantum firms
- Short Squeeze Potential: 16.5% short interest
- Technical Setup: Recovering from -11% pullback, RSI 58.9, MACD turning positive
- Analyst Support: $72 average target (37% upside), 7 Buy ratings
The Bad
- Massive Losses: $1.1B net loss in Q3 2025
- Insane Valuation: 234x price-to-sales ratio (industry average: 3-5x)
- Heavy Insider Selling: CEO sold $100M+, former Chair sold $230M+ in last 6 months
- No Profitability Path: Won't be profitable until 2028-2029 at earliest
- Technology Risk: Competing against Google, IBM, Microsoft with 100x the resources
The Verdict
- Graham's Test: FAILS all three investment criteria (1/7 score)
- Intrinsic Value: ~$7/share vs current price $52.69
- Margin of Safety: NEGATIVE 650%
- Classification: 100% SPECULATION, 0% INVESTMENT
TRADING PLAN
Entry
- Price: $52.00-$53.00 (limit order)
- Timing: December 8-9
- Size: 3 shares (~€150) for balanced approach
Exit Rules (NON-NEGOTIABLE)
- Stop Loss: Sell ALL at $47 (no excuses, no "waiting for recovery")
- Profit Targets:
- $60: Sell 50% (+14-16%)
- $65: Sell 30% (+23-25%)
- $72: Sell remaining 20% (+37%)
- Time Stop: Exit ALL by December 19 regardless of price
- News Stop: Exit immediately if government rumors prove false
Risk/Reward
- Upside: $13/share to $65 target (25%)
- Downside: $5.69/share to $47 stop (11%)
- Ratio: 2.3:1 (favorable for speculation)
POSITION SIZING: CRITICAL WARNING
Your Original Plan: 23.9% Allocation - REJECTED
This is DANGEROUSLY AGGRESSIVE and violates Graham's principles.
Recommended Alternatives:
Option A - Aggressive (if you have quality portfolio)
- IONQ: 2.4% of total portfolio (€304, 6 shares)
- ONLY if other 97.6% is in Graham-approved investments
Option B - Balanced (RECOMMENDED)
- IONQ: 1.2% of total portfolio (€150, 3 shares)
- Preserves capital for quality investments
- Still gives meaningful exposure to upside
Option C - Conservative
- IONQ: 0% (skip this trade entirely)
- Allocate to dividend stocks with P/E < 15
Why This Matters
If IONQ goes to $0 (possible with speculative stocks):
- At 23.9%: You lose 1/4 of your wealth
- At 2.4%: You lose 2.4% of your wealth
- At 1.2%: You lose 1.2% of your wealth
- At 0%: You lose nothing
CATALYST CALENDAR (Dec 8-19)
Watch For (Positive)
- Government quantum investment announcement
- Partnership announcements
- Analyst upgrades
- Short squeeze above $59
Watch Out For (Negative)
- Government rumors fizzle
- More insider selling
- Competitor breakthroughs
- Tech sector selloff
GRAHAM'S FINAL WARNING
"Obvious prospects for physical growth in a business do not translate into obvious profits for investors."
IonQ's quantum technology is impressive. But at 234x sales with no profits and massive insider selling, you're not buying a business—you're buying a lottery ticket.
As an INVESTMENT: Clear AVOID
As a 2-week SPECULATION: Acceptable IF sized at 1-3% max with strict stops
IF YOU TAKE THIS TRADE
You MUST:
- Accept you could lose 100% of this money
- Use the $47 stop loss (no exceptions)
- Exit by December 19 (no "let it ride")
- Keep position at 1-3% max (not 23.9%)
- Have the rest of your portfolio in quality investments
If you can't commit to all 5, DO NOT TAKE THIS TRADE.
QUICK REFERENCE
| Metric |
Value |
Assessment |
| Current Price |
$52.69 |
38% below 52-week high |
| Target Price |
$65 |
+23% upside |
| Stop Loss |
$47 |
-11% downside |
| Risk/Reward |
2.3:1 |
Favorable |
| Beta |
2.62 |
Extreme volatility |
| Short Interest |
16.5% |
Squeeze potential |
| Insider Selling |
Massive |
Major red flag |
| Profitability |
2028+ |
Years away |
| Graham Score |
1/7 |
Investment fail |
| Margin of Safety |
-650% |
None |
Full Analysis: See IONQ_TRADING_DESK_DECISION.md (15,000+ words)
Data Sources: Yahoo Finance, IonQ investor relations, Bloomberg, MarketBeat, Fintel
Report Date: December 6, 2025
Valid Through: December 19, 2025